A Stanford-led team developed a machine-learning model that predicts donor death timing, reducing canceled liver transplants and improving resource use.
Key Details
- 1A machine-learning model predicts whether donors will die within 30–45 minutes after life support removal, enabling timely liver transplantation.
- 2The model was trained on over 2,000 cases from six US transplant centers and outperformed surgeons’ judgment (75% vs 65% accuracy).
- 3Futile procurement rates (resources spent without a successful transplant) dropped by 60% using the model.
- 4Missed transplant opportunities remained similar to surgeon judgment (just over 15%), but further model refinements lowered this to ~10% in recent tests.
- 5The model incorporates donor demographics, vitals, lab results, ventilator settings, and neurological assessments, and features a natural language interface for clinical data extraction.
- 6It is customizable to clinical and hospital preferences and is being adapted for heart and lung transplantation.
Why It Matters
This research demonstrates the growing potential of machine learning in high-stakes surgical decision-making, supporting better allocation of scarce organs and healthcare resources. Increased accuracy and efficiency can enhance patient outcomes, reduce waste, and potentially expand AI's role into more imaging-driven and perioperative workflows.
Source
EurekAlert
Related News
•EurekAlert
AI-Driven CT Imaging Predicts Cardiac Events in Large UK Cohort
An AI tool analyzing CCTA images can predict future cardiovascular events and death in patients with suspected stable coronary artery disease.
•EurekAlert
AI Multimodal Models Improve Breast Cancer Recurrence Risk Prediction
Initial results from an ECOG-ACRIN and Caris Life Sciences collaboration show AI-driven multimodal models can more accurately predict recurrence risk in early-stage breast cancer.
•EurekAlert
AI Tool from UCLA Targets Undiagnosed Alzheimer's and Diagnostic Disparity
UCLA researchers developed an AI model using EHR data to better detect undiagnosed Alzheimer's disease, especially in underrepresented groups.